Related Experiment Video
Updated: Dec 26, 2025

10:43
Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
Published on: June 27, 2014
20.4K
3D printer-based novel intensity-modulated vaginal brachytherapy applicator: feasibility study
Fatih Biltekin1, Husnu Fadil Akyol1, Melis Gültekin1
1Department of Radiation Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Journal of Contemporary Brachytherapy
|March 20, 2020
Summary
A new high-dose-rate brachytherapy applicator was designed for gynecological cancers, enabling enhanced dose modulation. Quality control tests confirmed its mechanical and dosimetric accuracy for clinical use.
Area of Science:
- Medical Physics
- Oncology
- Biomedical Engineering
Background:
- Brachytherapy is crucial for gynecological cancer treatment.
- Current applicators may have limitations in dose modulation.
- Novel applicator design aims to improve treatment precision.
Purpose of the Study:
- To design and evaluate a novel high-dose-rate intracavitary applicator for gynecological brachytherapy.
- To achieve enhanced dose modulation capabilities.
- To ensure mechanical and dosimetric accuracy through rigorous testing.
Main Methods:
- 3D modeling and printing (polylactic acid filament) of the applicator and phantom.
- Mechanical tests: source-dwell positioning accuracy, reproducibility, and linearity.
- Dosimetric tests: point dose and 2D dose distribution validation against treatment planning system calculations.
- Measurements performed on a Varian GammaMed iX Plus unit using iridium-192 (192Ir).
Main Results:
- Mechanical tests showed source-dwell positioning accuracy ≤ 0.5 mm and linearity ≤ 1.5%.
- Treatment planning reproducibility met 97.7% gamma evaluation criteria (1 mm/1%).
- Dosimetric tests revealed a maximum point dose difference of 3.8% and >90% passing points in 2D analysis (3 mm/3%).
Conclusions:
- The designed novel brachytherapy applicator successfully met all quality control requirements.
- The applicator demonstrates feasibility for clinical application in gynecological brachytherapy.
- This innovation holds potential for improved dose modulation and treatment outcomes.

